BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 30200715)

  • 1. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
    Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
    Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Hugan Qingzhi tablets on AMPK pathway activation and NF-κB-p65 protein expression in the liver of rats with nonalcoholic fatty liver disease].
    Yao XR; Xia F; Tang WJ; Zhou BJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 Jan; 37(1):56-62. PubMed ID: 28109099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal medicine mixture 919 syrup alleviates nonalcoholic fatty liver disease in rats by inhibiting the NF-κB pathway.
    Chen M; Xing J; Pan D; Peng X; Gao P
    Biomed Pharmacother; 2020 Aug; 128():110286. PubMed ID: 32521450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease.
    Yang JM; Sun Y; Wang M; Zhang XL; Zhang SJ; Gao YS; Chen L; Wu MY; Zhou L; Zhou YM; Wang Y; Zheng FJ; Li YH
    World J Gastroenterol; 2019 Sep; 25(34):5105-5119. PubMed ID: 31558860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of catgut embedding at back-
    Zhou XL; Tang N; Wu T; Zhang Y; Chen Q; Wei WH; Zhou YN; Zhang DX; Qin FC; Yang W
    Zhongguo Zhen Jiu; 2020 Jan; 40(1):59-66. PubMed ID: 31930901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
    Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
    Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
    Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ
    Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of Chinese herbal medicine Jiangzhi Granule on expressions of liver X receptor α and sterol regulatory element-binding protein-1c in a rat model of non-alcoholic fatty liver disease].
    Yang LL; Wang M; Liu T; Song HY; Li DF; Zheng PY; Liu P; Ji G; Ji G
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):998-1004. PubMed ID: 21906525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
    Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Dangfei Liganning capsule on liver X receptor α/steroid regulatory element binding protein-1/fatty acid synthase signal pathway in rats with metabolic- associated fatty liver disease.
    Xiaoling LI; Fengxia S; Zimeng S; Yingxue Z; Jie LI; Qiuxiang Z
    J Tradit Chin Med; 2022 Dec; 42(6):940-947. PubMed ID: 36378052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of soothing liver and invigorating spleen recipes on SREBP-1c mRNA and protein expression in hepatic tissues of rats with non-alcoholic fatty liver disease].
    He XM; Yang QH; Li PF; Chen Z; Feng GF; Wang WJ; Liu HT; Zhang YP; Ji GY
    Zhong Yao Cai; 2011 Jun; 34(6):931-7. PubMed ID: 22017010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine inhibits liver damage in rats with non-alcoholic fatty liver disease by regulating TLR4/MyD88/NF-κB pathway.
    Wang L; Jia Z; Wang B; Zhang B
    Turk J Gastroenterol; 2020 Dec; 31(12):902-909. PubMed ID: 33626003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of geniposide in improving free fatty acid metabolism in rats with non-alcoholic fatty liver disease].
    Liang HQ; Lin MT; Zhao X; Zhou HH; Wang HG; Li GH; Wang YJ; Zhang LM; Wang YY; Chen SD
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(3):470-475. PubMed ID: 28868866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
    Zheng H; Hong SC; Yu J; Wen XY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):846-52. PubMed ID: 25137852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
    Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
    Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role and mechanism of action of fibroblast growth factor-21 in reducing triglyceride in nonalcoholic fatty liver disease].
    Chen L; Jiang M; Xin Y; Wang J; Liu Y; Jiang X; Xuan S
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):102-7. PubMed ID: 26983476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Buyang Huanwu Decoction on mRNA Expressions of Aorta Rho Kinase and NF-κB p65 in Atherosclerosis Model Rats].
    Zhang HZ; Li L; Jiao R; Zhang Y; Qian Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Dec; 35(12):1495-500. PubMed ID: 26882614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nuclear factor-κB and angiotensin II receptor type 1 on the pathogenesis of rat non-alcoholic fatty liver disease.
    Tan DY; Shi HY; Li CP; Zhong XL; Kang M
    World J Gastroenterol; 2015 May; 21(19):5877-83. PubMed ID: 26019451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
    World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.